<span item_type="fundamental" item_id="a1feaa9c314c510c6c032c3838c1702f" counter_id="ST/US/HIT" env="prod"></span><span item_type="announcement" item_id="581924697123134721" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 8.49 M.</p><p>EPS: As of FY2025 Q3, the actual value is USD 0.01.</p><p>EBIT: As of FY2025 Q3, the actual value is USD 381.82 K.</p><p></p><h3>Segment Revenue</h3><ul><li>Total revenue for the third quarter of 2025 was $8.5 million, representing a 90% increase year over year. For the nine months ended September 30, 2025, total revenue was $25.8 million, which is 132% of the full-year 2024 revenue.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>Pre-tax income for the third quarter was $0.6 million, up 48% year over year, and for the nine months ended September 30, 2025, it was $2.1 million, representing 238% of the full-year 2024 pre-tax income.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li><li>Adjusted EBITDA for the third quarter was $1.0 million, an increase of 49% year over year, and for the nine months ended September 30, 2025, it was $3.8 million, or 167% of the full-year 2024 total.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li><li>Gross profit for the third quarter was $5.1 million, compared to $3.5 million in the same period of 2024. For the nine months ended September 30, 2025, gross profit was $16.8 million, compared to $11.6 million in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li><li>Total operating expenses for the third quarter were $4.7 million, compared to $3.0 million in the same period of 2024. For the nine months ended September 30, 2025, total operating expenses were $15.1 million, compared to $10.3 million in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>Net cash provided by operating activities for the nine months ended September 30, 2025, was $2.7 million, compared to $2.7 million in the same period of 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li><li>Net cash used in investing activities for the nine months ended September 30, 2025, was - $2.4 million, compared to - $0.3 million in the same period of 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li><li>Net cash used in financing activities for the nine months ended September 30, 2025, was - $0.2 million, compared to - $3.1 million in the same period of 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li>The number of billed enrolled employees was 25,248, an increase of 7,654 employees year over year.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li><li>The number of brokers, third-party administrators, and agencies expanded to 849 partners as of September 30, 2025, up 57% year over year.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li></ul><h3>Outlook / Guidance</h3><ul><li>Health In Tech is focused on expanding its distribution ecosystem and enhancing its technology platform capabilities, aiming for sustained revenue momentum and operational efficiency.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li><li>The company is exploring blockchain-enabled solutions to modernize claims administration, targeting efficiency gains in the $300 billion U.S. claims market.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li><li>Health In Tech plans to host its first Independent InsurTech Summit during the World Economic Forum week in Davos, highlighting its influence in shaping global industry dialogue.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2019505/000121390025108530/ea026512901ex99-1_healthin.htm"></span></li></ul>

Health In Tech | 8-K: FY2025 Q3 Revenue: USD 8.49 M